Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCARGO Therapeutics, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$1.09 | -$0.82 | -$0.94 |
| Q2 2025 | 2 | -$0.94 | -$0.94 | -$0.94 |
| Q3 2025 | 2 | -$0.96 | -$0.96 | -$0.96 |
| Q4 2025 | 2 | -$1.00 | -$1.00 | -$1.00 |
| Q1 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q2 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q3 2026 | 1 | -$0.93 | -$0.93 | -$0.93 |
| Q4 2026 | 1 | -$0.74 | -$0.74 | -$0.74 |
| Q1 2027 | 1 | -$0.49 | -$0.49 | -$0.49 |
| Q2 2027 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q3 2027 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q4 2027 | 1 | -$0.22 | -$0.22 | -$0.22 |
CARGO Therapeutics, Inc. Common Stock Earnings Date And Information
CARGO Therapeutics, Inc. Common Stock last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.88 earnings per share for the quarter, topping analysts' consensus estimates of $-1.14 by $0.26. The company had revenue of 0 for the quarter and had revenue of 0 for the year. CARGO Therapeutics, Inc. Common Stock has generated $-2 earnings per share over the last year ($-2.38 diluted earnings per share) and currently has a price-to-earnings ratio of -3.83. CARGO Therapeutics, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based on prior year's report dates.
CARGO Therapeutics, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$1.14 | -$0.88 | 0.26 | $0 | $0 |
| 08/12/2024 | Q2 2024 | -$1.06 | -$1.02 | 0.04 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$1.05 | -$0.87 | 0.18 | $0 | |
| 03/21/2024 | Q4 2023 | -$1.62 | -$0.78 | 0.84 | $0 | |
| 12/13/2023 | Q3 2023 | -$0.92 | $0 | |||
| 06/29/2023 | Q2 2023 | -$0.46 | $0 | |||
| 03/30/2023 | Q1 2023 | -$0.33 | $0 | |||
| 12/30/2022 | Q4 2022 | -$0.47 | $0 | |||
| 09/29/2022 | Q3 2022 | -$0.63 | $0 |
CARGO Therapeutics, Inc. Common Stock Earnings: FAQ's
When is CARGO Therapeutics, Inc. Common Stock's earnings date?
CARGO Therapeutics, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates.
Did CARGO Therapeutics, Inc. Common Stock beat their earnings estimates last
quarter?
In the previous quarter, CARGO Therapeutics, Inc. Common Stock (:CRGX) reported $-0.88 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.14 by $0.26.
How can I listen to CARGO Therapeutics, Inc. Common Stock's earnings conference
call?
The conference call for CARGO Therapeutics, Inc. Common Stock's latest earnings report can be listened to online.
How can I read CARGO Therapeutics, Inc. Common Stock's conference call transcript?
The conference call transcript for CARGO Therapeutics, Inc. Common Stock's latest earnings report can be read online.
How much profit does CARGO Therapeutics, Inc. Common Stock generate each year?
CARGO Therapeutics, Inc. Common Stock (:CRGX) has a recorded net income of $0. CARGO Therapeutics, Inc. Common Stock has generated $-2.38 earnings per share over the last four quarters.
What is CARGO Therapeutics, Inc. Common Stock's price-to-earnings ratio?
CARGO Therapeutics, Inc. Common Stock (:CRGX) has a price-to-earnings ratio of -3.83 and price/earnings-to-growth ratio is -3.44.